ASCO GU 2022: Choosing between combination treatments for advanced kidney cancer
Combination therapies have revolutionised the first-line treatment of metastatic clear [...]
Combination therapies have revolutionised the first-line treatment of metastatic clear [...]
This report looked at the results from 4 studies comparing [...]
This phase 2 study looked at the use of stereotactic [...]
There is increasing interest in using treatment breaks to reduce [...]
This study compared disease outcomes, treatments, and dose reductions in [...]
Dr Sumanta (Monty) Pal, Clinical Professor and Co-Director of the [...]
This article summarises the key breakthroughs in the treatment of [...]
Cytoreductive nephrectomy is the removal of the tumour to reduce [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
During this online interview, the approach to selection of first-line [...]